Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aerovate Therapeutics Inc

AVTE
Current price
2.79 USD +0.3 USD (+12.05%)
Last closed 2.45 USD
ISIN US0080641071
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 63 509 048 USD
Yield for 12 month -75.68 %
1Y
3Y
5Y
10Y
15Y
AVTE
21.11.2021 - 28.11.2021

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts. Address: 930 Winter Street, Waltham, MA, United States, 02451

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-96 000 USD

Last Year

-68 000 USD

Current Quarter

-28 000 USD

Last Quarter

-28 000 USD

Key Figures AVTE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -94 108 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -44.04 %
PEG Ratio
Return On Equity TTM -74.42 %
Wall Street Target Price 2.33 USD
Revenue TTM
Book Value 3.27 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.13 USD
Diluted Eps TTM -3.13 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AVTE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AVTE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AVTE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -9.3264
Price Book MRQ 0.6483

Financials AVTE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVTE

For 52 weeks

1.25 USD 32.42 USD
50 Day MA 2 USD
Shares Short Prior Month 846 446
200 Day MA 12.71 USD
Short Ratio 2.99
Shares Short 664 994
Short Percent 5.87 %